340B Drug Pricing Program
AHA joined by others ask U.S. Supreme Court to hear cases on 340B, hospital outpatient payment cuts
QUESTION PRESENTED: The question presented is whether Chevron deference permits HHS to set reimbursement rates based on acquisition cost and vary such rates by hospital group if it has not collected adequate hospital acquisition cost survey data.
Please contact your representatives and ask them to sign onto a
Plaintiffs' Response to Order to Show Cause Opposition to Defendants' Motion to Dismiss and Reply in Support of Plaintiffs' Motion for a Preliminary Injunction Re: 340B Contract Pharmacy
Order to show Cause RE: Dismissal for Lack of Subject-Matter Jurisdiction
Please contact your representatives today and ask them to sign onto a bipartisan “Dear Colleague” letter to Xavier Becerra, the nominee for Department of Health and Human Services Secretary, asking him to take immediate action to ensure that manufacturers are prohibited from imposing unilateral…
Yesterday counsel for AHA and the four other national groups participants and three individual hospital systems that sued the Department of Health and Human Services over its failure to halt drug company actions that undermine the 340B program sent letters demanding that the offending…
AHA urges drug companies urged to provide discounts to 340B community pharmacies.
The Department of Health and Human Services Office of the General Counsel Dec.
AHA statement on HHS advisory opinion on 340B drug discounts from President and CEO Rick Pollack.